IQM’s State of Quantum 2025: Quantum Industry Must Solve Talent Shortage and Software Platforms, Not Just Qubits
IQM Quantum Computers in collaboration with analyst firm Omdia (LON:INF), today unveiled the third edition of its State of Quantum Report, revealing that the quantum industry must address talent shortages and software development kits (SDK) gaps in order to scale beyond just qubit count.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250610552224/en/
IQM State of Quantum 2025 Report
As quantum computing shifts from theoretical promise to practical integration, the report projects that the global quantum computing market will reach over $22 billion by 2032 as commercial deployments accelerate.
The findings also show that 75% of respondents believe that defining the right applications is the most critical factor for adoption. As Dr. Jan Goetz, Co-CEO and Co-founder of IQM, noted in his foreword, “Quantum’s promise is clear, but fulfilling it requires orchestrated progress across the hardware and software stack—transforming these powerful machines from niche tools into drivers of real-world outcomes.”
The report also argues that progress hinges on synchronising hardware industrialisation with software platform maturity. Today, software development kit fragmentation hampers portability and slows adoption in multi-vendor settings.
HPC, Quantum, and AI Integration
The report also highlights how high-performance computing (HPC), quantum computing, and AI are converging to drive the next wave of growth. According to industry experts, investors, and users across Europe, North America, Asia, and Oceania interviewed, HPC provides the robust infrastructure and orchestration needed to integrate quantum systems into real-world environments, ensuring that quantum and classical resources work in harmony.
This synergy promises to accelerate adoption, amplify returns for early adopters, and transform quantum computing from a niche capability into a trusted part of the broader scientific and industrial toolbox.
“Our interviewees identified three major challenges – one is getting to the level of reliability where quantum computers can be considered industrial products rather than crafted laboratory devices, another is improving the software layer to provide the sort of developer experience we see in the high-level frameworks used for AI, and a third is helping users identify opportunities to benefit from quantum computer and set up their experiments. Interestingly, the interviewees are expecting multiple quantum technologies to co-exist, with a degree of specialisation between them,” said Alexander Harrowell, Principal Analyst, Advanced Computing at Omdia.
Key Findings and Market Trends
- Sector Readiness: 57% of survey respondents placed drug-discovery and molecular-modelling workloads as their top quantum priority list, ahead of finance and chemicals.
- Funding: After a dip in 2023, venture funding surged again in 2024, with 58% of cumulative quantum venture funding still flowing to North American firms, with average deal sizes ($38M) triple those in Europe ($12M).
- Challenges Ahead: Talentshortages in quantum and growth-stage funding outside the US are the two biggest systemic risks to the industry’s continued growth.
In addition, the report also calls for three critical priorities to turn these insights into tangible outcomes:
- Better Abstraction Layers: Bridging the gap between the physics of qubits and the practical problems that matter to businesses.
- Unified Orchestration and Scheduling: Enabling quantum and classical HPC resources to operate seamlessly together.
- Cross-Disciplinary Collaboration: Fostering teams that blend quantum expertise, domain knowledge, and software development—creating a new generation of problem-solvers.
Download the full report here: State of Quantum 2025 Report.
About IQM Quantum Computers:
IQM is a global leader in superconducting quantum computers. IQM provides both on-premises full-stack quantum computers and a cloud platform to access its computers. IQM customers include the leading high-performance computing centres, research labs, universities and enterprises which have full access to IQM's software and hardware. IQM has over 300 employees with headquarters in Finland and a global presence in France, Germany, Italy, Japan, Poland, Spain, Singapore, South Korea and the United States.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250610552224/en/
Contacts
Media contact:
Email: press@meetiqm.com
Mobile: +358504790845
www.meetiqm.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.meetiqm.com
%2F&esheet=54271859&newsitemid=20250610552224&lan=en-US&anchor=www.meetiqm.com&i
ndex=3&md5=87b40de36977a003614d90fe93e9a4ec
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion15.12.2025 12:30:00 CET | Press Release
SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values the Company in excess of EUR €1.5 billion. Swixx is the global leader in rest-of-world pharmaceutical commercialization services dedicated to delivering innovative, life-saving medications to underserved and hard-to-reach markets. Stuart Swanson and Petr Němec, Swixx’s Co-Founders, and Jean-Michel Lespinasse and Petr Pipal, Swixx’s CEO and CFO, respectively, will all retain significant ownership stakes in Swixx as part of the transaction. Existing institutional investors HBM Healthcare Investments, a Swiss-listed investment company for the global healthcare market, and Mérieux Equity Partners, a leading healthcare-specializ
Safe Software Recognized as a Niche Player in 2025 Gartner® Magic Quadrant™ for Data Integration Tools15.12.2025 12:00:00 CET | Press Release
Safe Software, a global leader in data integration and transformation, has once again been recognized in the 2025 Gartner® Magic Quadrant™ for Data Integration Tools, marking the sixth consecutive year the company has been included in this prestigious report. Safe Software’s FME Platform has evolved well beyond its geospatial roots to become the only All-Data, Any-AI Integration Platform, empowering organizations worldwide to connect all data, applications, and AI technologies anywhere, at any scale, and with complete flexibility. With a community of more than 200,000 enthusiastic users and 25,000+ organizations in over 125 countries, FME continues to redefine data integration by delivering a no-code enterprise solution that unifies data movement, automation, and AI connectivity. “Our continued recognition reflects the trust of our customers and the innovation of our team,” said Don Murray, CEO and Co-Founder of Safe Software. “We’re proud to help organizations integrate data seamlessl
GENESIS Pharma announces a new partnership with Otsuka Pharmaceutical Europe Ltd. for the commercialization of donidalorsen for hereditary angioedema in Central and Eastern Europe15.12.2025 10:00:00 CET | Press Release
ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GENESIS Pharma, a regional biopharma company focused on the commercialization of innovative medicines in Central and Eastern Europe, announces an exclusive agreementwithOtsuka Pharmaceutical Europe Ltd. (OPEL), the European operation of global healthcare company Otsuka Pharmaceutical Co., Ltd., for donidalorsen. Under the terms of the agreement, GENESIS Pharma will exclusively distribute and commercializedonidalorsen in fourteen markets: Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia and Slovenia. In November 2025, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for donidalorsen in the routine prevention of recurrent attacks of hereditary angioedema (HAE) in adults and adolescents aged 12 years and older. The CHMP opinion is c
BitGo yn Sicrhau Cymeradwyaeth OCC i Drosi i Fanc Ymddiriedolaeth Genedlaethol Siartredig Ffederal13.12.2025 02:13:00 CET | Pressmeddelande
Cyhoeddodd BitGo Holdings, Inc. (“BitGo”), y cwmni seilwaith asedau digidol, heddiw fod Swyddfa Rheolwr yr Arian Cyfred (“OCC”) wedi cymeradwyo ei gais i drosi BitGo Trust Company, Inc., cwmni ymddiriedolaeth siartredig De Dakota, i fanc cenedlaethol o'r enw BitGo Bank & Trust, National Association (N.A.). Gyda chymeradwyaeth OCC heddiw o'i drosi, mae is-gwmni Cwmni Ymddiriedolaeth BitGo bellach yn gweithredu fel BitGo Bank & Trust, National Association (N.A.). Bydd BitGo Bank & Trust, N.A. yn gweithredu o dan un gyfundrefn oruchwylio ffederal unffurf, gan ei alluogi i ddarparu'r eglurder, y llywodraethiant, a'r sicrwydd rheoleiddiol y mae sefydliadau'n eu disgwyl gan ymddiriedolwr a reoleiddir yn ffederal. Mae'r gymeradwyaeth hon yn atgyfnerthu safle BitGo fel sylfaen sefydliadol ar gyfer y system ariannol fodern, gan gyfuno goruchwyliaeth ar lefel banc â'r diogelwch, y cydymffurfiaeth, a'r graddadwyedd sy'n diffinio seilwaith BitGo. O dan siarter y banc cenedlaethol, ac yn amodol ar
FIA, Formula 1 Group and All 11 Race Teams Officially Sign the Ninth Concorde Agreement, Securing Strength and Stability for the Sport in Pivotal Five-Year Agreement12.12.2025 17:10:00 CET | Press Release
The Fédération Internationale de l'Automobile (FIA), the global governing body for motor sport and the federation for mobility organisations worldwide, and Formula 1 Group, the Commercial Rights Holder, have today announced the signing of the Concorde Governance Agreement, a crucial contract defining the regulatory framework and governance terms of the FIA Formula One World Championship until 2030. This follows the announcement in March that the 2026 Commercial Concorde Agreement had been signed by all the teams and Formula 1 Group. Together, these agreements constitute the ninth Concorde Agreement, representing a major step forward in the professionalisation and global development of the sport. First introduced in 1981, the Concorde Agreements are designed to promote sporting fairness, technological innovation and operational excellence, and align all key stakeholders around a shared vision for structured governance and continued growth of the sport. Each iteration of the Concorde Agr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom